Stock ONCT ONCTERNAL THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Charts Oncternal Therapeutics, Inc.

Equities

ONCT

US68236P2065

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-04-26 pm EDT 		5-day change 1st Jan Change
8.29 USD +0.48% Intraday chart for Oncternal Therapeutics, Inc. -6.43% -22.70%
Apr. 18 Oncternal Announces First Patient Dosed in Fourth Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer CI
Apr. 15 HC Wainwright Cuts Oncternal Therapeutics' Price Target to $28 From $30, Keeps Buy Rating MT

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Neutral

Neutral

Neutral

Resistance 9.400 12.80 11.96
Spread/Res.-11.81%-35.23%-30.69%
Spread/Supp.+6.28%+42.93%+42.93%
Support 7.800 5.800 5.800

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. ONCT Stock
  4. Charts Oncternal Therapeutics, Inc.